Back to Search Start Over

Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19

Authors :
Wouter M. Sluis
Marijke Linschoten
Julie E. Buijs
J. Matthijs Biesbroek
Heleen M. den Hertog
Tessa Ribbers
Dennis J. Nieuwkamp
Reinier C. van Houwelingen
Andreas Dias
Ingeborg W.M. van Uden
Joost P. Kerklaan
H. Paul Bienfait
Sarah E. Vermeer
Sonja W. de Jong
Mariam Ali
Marieke J.H. Wermer
Marieke T. de Graaf
Paul J.A.M. Brouwers
Folkert W. Asselbergs
L. Jaap Kappelle
H. Bart van der Worp
Annemijn M. Algra
Richard C.J.M. Donders
D. Martijn O. Pruissen
Aaf F.M. Kuijper
Clara E.E. van Ofwegen-Hanekamp
Rik S. Hermanides
Hortence E. Haerkens-Arends
Rutger L. Anthonio
Mireille E. Emans
René A. Tio
Jur M. ten Berg
Björn E. Groenemeijer
Ron Pisters
P. Marc van der Zee
Hans-Marc J. Siebelink
Derk O. Verschure
Matthijs F.L. Meijs
Astrid Schut
Robert G. Tieleman
Wanda Hermans-van Ast
Jeroen Schaap
Lucia S. Jewbali
Peter C. Smits
Pim van der Harst
Maarten van Smeden
Wiek H. van Gilst
Cardiovascular Centre (CVC)
Neurology
Cardiology
Neurosurgery
Intensive Care
Source :
Stroke, 52(12), 3978-3986. LIPPINCOTT WILLIAMS & WILKINS, Stroke, 52(12), 3978-3986. Lippincott Williams and Wilkins, Stroke, 52(12), 3978-3986. Lippincott Williams & Wilkins
Publication Year :
2021

Abstract

Background and Purpose: The frequency of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) varies in the current literature, and risk factors are unknown. We assessed the incidence, risk factors, and outcomes of acute ischemic stroke in hospitalized patients with COVID-19. Methods: We included patients with a laboratory-confirmed SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infection admitted in 16 Dutch hospitals participating in the international CAPACITY-COVID registry between March 1 and August 1, 2020. Patients were screened for the occurrence of acute ischemic stroke. We calculated the cumulative incidence of ischemic stroke and compared risk factors, cardiovascular complications, and in-hospital mortality in patients with and without ischemic stroke. Results: We included 2147 patients with COVID-19, of whom 586 (27.3%) needed treatment at an intensive care unit. Thirty-eight patients (1.8%) had an ischemic stroke. Patients with stroke were older but did not differ in sex or cardiovascular risk factors. Median time between the onset of COVID-19 symptoms and diagnosis of stroke was 2 weeks. The incidence of ischemic stroke was higher among patients who were treated at an intensive care unit (16/586; 2.7% versus nonintensive care unit, 22/1561; 1.4%; P =0.039). Pulmonary embolism was more common in patients with (8/38; 21.1%) than in those without stroke (160/2109; 7.6%; adjusted risk ratio, 2.08 [95% CI, 1.52–2.84]). Twenty-seven patients with ischemic stroke (71.1%) died during admission or were functionally dependent at discharge. Patients with ischemic stroke were at a higher risk of in-hospital mortality (adjusted risk ratio, 1.56 [95% CI, 1.13–2.15]) than patients without stroke. Conclusions: In this multicenter cohort study, the cumulative incidence of acute ischemic stroke in hospitalized patients with COVID-19 was ≈2%, with a higher risk in patients treated at an intensive care unit. The majority of stroke patients had a poor outcome. The association between ischemic stroke and pulmonary embolism warrants further investigation.

Details

Language :
English
ISSN :
00392499
Volume :
52
Issue :
12
Database :
OpenAIRE
Journal :
Stroke
Accession number :
edsair.doi.dedup.....3bdef6d527a91e1daeac6ec5170ab0d2